These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 27342833)
1. Phase II clinical study of neoadjuvant chemotherapy with CDDP/CPT-11 regimen in combination with radical hysterectomy for cervical cancer with a bulky mass. Shoji T; Takatori E; Furutake Y; Takada A; Nagasawa T; Omi H; Kagabu M; Honda T; Miura F; Takeuchi S; Kumagai S; Yoshizaki A; Sato A; Sugiyama T Int J Clin Oncol; 2016 Dec; 21(6):1120-1127. PubMed ID: 27342833 [TBL] [Abstract][Full Text] [Related]
2. [Results of neoadjuvant chemotherapy using tri-weekly CDDP/CPT-11 for locally advanced cervical cancer]. Shoji T; Takatori E; Murai M; Hatayama S; Omi H; Kagabu M; Honda T; Kumagai S; Morohara Y; Yoshizaki A; Sugiyama T; Kaido Y; Miura F; Satoh A Gan To Kagaku Ryoho; 2010 Apr; 37(4):643-8. PubMed ID: 20414019 [TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy with docetaxel and carboplatin followed by radical hysterectomy for stage IB2, IIA2, and IIB patients with non-squamous cell carcinoma of the uterine cervix. Shimada M; Nagao S; Fujiwara K; Takeshima N; Takizawa K; Shoji T; Sugiyama T; Yamaguchi S; Nishimura R; Kigawa J Int J Clin Oncol; 2016 Dec; 21(6):1128-1135. PubMed ID: 27380169 [TBL] [Abstract][Full Text] [Related]
4. Analysis of prognostic factors for patients with bulky squamous cell carcinoma of the uterine cervix who underwent neoadjuvant chemotherapy followed by radical hysterectomy. Takatori E; Shoji T; Omi H; Kagabu M; Miura F; Takeuchi S; Kumagai S; Yoshizaki A; Sato A; Sugiyama T Int J Clin Oncol; 2015 Apr; 20(2):345-50. PubMed ID: 24825458 [TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancer. Abou-Taleb HA; Koshiyama M; Matsumura N; Baba T; Yamaguchi K; Hamanishi J; Abiko K; Yamanoi K; Murakami R; Horikawa N; Taha AA; Kitamura S; Konishi I J Int Med Res; 2016 Apr; 44(2):346-56. PubMed ID: 26831404 [TBL] [Abstract][Full Text] [Related]
6. Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065). Yamaguchi S; Nishimura R; Yaegashi N; Kiguchi K; Sugiyama T; Kita T; Kubushiro K; Kokawa K; Hiura M; Mizutani K; Yamamoto K; Takizawa K Oncol Rep; 2012 Aug; 28(2):487-93. PubMed ID: 22614251 [TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy followed by radical hysterectomy plus postoperative chemotherapy but no radiotherapy for Stage IB2-IIB cervical cancer--irinotecan and platinum chemotherapy. Matsumura M; Takeshima N; Ota T; Omatsu K; Sakamoto K; Kawamata Y; Umayahara K; Tanaka H; Akiyama F; Takizawa K Gynecol Oncol; 2010 Nov; 119(2):212-6. PubMed ID: 20709382 [TBL] [Abstract][Full Text] [Related]
8. Phase I Dose-Escalation Study of Weekly Paclitaxel and Cisplatin Followed by Radical Hysterectomy in Stages IB2 and IIA2 Cervical Cancer. Chou HH; Huang HJ; Lin H; Yang LY; Hsueh S; Liu FY; Liou YL; Liou JD; Chen MY; Chao A; Lin G; Chang TC; Lai CH Am J Clin Oncol; 2017 Jun; 40(3):241-249. PubMed ID: 25350466 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of neoadjuvant chemotherapy plus radical surgery in patients with bulky stage II cervical squamous cell carcinoma: A retrospective cohort study. Qin T; Zhen J; Zhou M; Wu H; Ren R; Qu B; Wang H Int J Surg; 2016 Jun; 30():121-5. PubMed ID: 27131759 [TBL] [Abstract][Full Text] [Related]
10. Multi-institutional phase II study of neoadjuvant irinotecan and nedaplatin followed by radical hysterectomy and the adjuvant chemotherapy for locally advanced, bulky uterine cervical cancer: A Kansai Clinical Oncology Group study (KCOG-G1201). Mori T; Makino H; Okubo T; Fujiwara Y; Sawada M; Kuroboshi H; Tsubamoto H; Murakoshi H; Motohashi T; Kitawaki J; Ito K J Obstet Gynaecol Res; 2019 Mar; 45(3):671-678. PubMed ID: 30575239 [TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant weekly carboplatin and paclitaxel followed by radical hysterectomy for locally advanced cervical cancer: long-term results. Mori T; Hosokawa K; Sawada M; Kuroboshi H; Tatsumi H; Koshiba H; Okubo T; Kitawaki J Int J Gynecol Cancer; 2010 May; 20(4):611-6. PubMed ID: 20686381 [TBL] [Abstract][Full Text] [Related]
12. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy]. Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176 [TBL] [Abstract][Full Text] [Related]
13. [Neoadjuvant chemotherapy with cisplatin and CPT-11 for advanced cervical cancer]. Nishio S; Kumagai S; Hirai N; Tomioka Y; Oota S; Fujiyoshi K; Hasuo Y; Sugiyama T; Nishida T; Kamura T Gan To Kagaku Ryoho; 2000 Mar; 27(3):429-35. PubMed ID: 10740637 [TBL] [Abstract][Full Text] [Related]
14. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer. Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834 [TBL] [Abstract][Full Text] [Related]
15. A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation. Dueñas-Gonzalez A; López-Graniel C; González-Enciso A; Cetina L; Rivera L; Mariscal I; Montalvo G; Gómez E; de la Garza J; Chanona G; Mohar A Ann Oncol; 2003 Aug; 14(8):1278-84. PubMed ID: 12881393 [TBL] [Abstract][Full Text] [Related]
16. Cisplatin with dose-dense paclitaxel before and after radical hysterectomy for locally advanced cervical cancer: a prospective multicenter phase II trial with a dose-finding study. Tanioka M; Yamaguchi S; Shimada M; Nagao S; Takehara K; Nishimura M; Morita S; Negoro S; Fujiwara K; Kigawa J Med Oncol; 2017 Aug; 34(8):134. PubMed ID: 28681218 [TBL] [Abstract][Full Text] [Related]
17. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma]. Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113 [TBL] [Abstract][Full Text] [Related]
18. Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer. Sugiyama T; Nishida T; Kumagai S; Nishio S; Fujiyoshi K; Okura N; Yakushiji M; Hiura M; Umesaki N Br J Cancer; 1999 Sep; 81(1):95-8. PubMed ID: 10487618 [TBL] [Abstract][Full Text] [Related]
19. Treatment of stage IB2, IIA bulky cervical cancer: a single-institution experience of neoadjuvant chemotherapy followed by radical hysterectomy and primary radical hysterectomy. Lee JY; Kim YH; Kim MJ; Kim K; Chung HH; Park NH; Song YS; Kang SB Arch Gynecol Obstet; 2011 Aug; 284(2):477-82. PubMed ID: 20878172 [TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy using platinum- and taxane-based regimens for bulky stage Ib2 to IIb non-squamous cell carcinoma of the uterine cervix. Shoji T; Takatori E; Saito T; Omi H; Kagabu M; Miura F; Takeuchi S; Sugiyama T Cancer Chemother Pharmacol; 2013 Mar; 71(3):657-62. PubMed ID: 23263187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]